Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
Simon Dujardin(Harvard University), Caitlin Commins(Massachusetts General Hospital), Aurélien Lathuilière(Harvard University), Pieter Beerepoot(Boston Children's Hospital), Analiese R. Fernandes(Massachusetts General Hospital), Tarun Kamath(Massachusetts General Hospital), Mark B. De Los Santos(Massachusetts General Hospital), Naomi Klickstein(Massachusetts General Hospital), Diana L. Corjuc(Massachusetts General Hospital), Bianca T. Corjuc(Massachusetts General Hospital), Patrick M. Dooley(Massachusetts General Hospital), Arthur Viodé(Boston Children's Hospital), Derek H. Oakley(Harvard University), Ben D. Moore(Harvard University), Kristina Mullin(Massachusetts General Hospital), Dinorah Jean-Gilles(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ryan Clark(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Renée Moore(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lori B. Chibnik(Harvard University), Rudolph E. Tanzi(Harvard University), Matthew P. Frosch(Harvard University), Alberto Serrano‐Pozo(Harvard University), Fiona Elwood(Merck & Co., Inc., Rahway, NJ, USA (United States)), Judith A. Steen(Boston Children's Hospital), Matthew Kennedy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bradley T. Hyman(Harvard University)
Cited by 8Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis